EMBC (Embecta Inc.) יחס שווי שוק לשווי בספרים

The price history of Embecta Corp. (EMBC), spun off from Becton Dickinson, reflects the dynamics of a leader in the insulin injection segment with a market share of approximately 40%. Working capital stability and liquidity at the level of -0.63 are supported by steady demand for consumables. The business relies on the mass production of needles and syringes, ensuring regular supplies to millions of people with diabetes worldwide.

This ratio compares the market value of the business with its net assets, determining the premium or discount to book value amid inflationary pressures. For Embecta Corp. (EMBC), which possesses absolute pricing power in the essential goods segment for diabetics, the price-to-book multiplier chart reflects the resilience of the share price, underpinned by global dominance and inelastic demand for its products.